Abiopharma

Asset Acquisitions and Disposals: ANNOUNCEMENT PURSUANT TO RULE 706A OF THE LISTING MANUAL

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023651 <b>Size:</b> 779 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023652 <b>Size:</b> 1 MB

New Form FWP - CANADIAN IMPERIAL BANK OF COMMERCE /CAN/ <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023653 <b>Size:</b> 74 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023650 <b>Size:</b> 987 KB

New Form SCHEDULE 13G/A - GARTNER INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001167557-26-000187 <b>Size:</b> 8 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023649 <b>Size:</b> 693 KB

Accelerant Announces Second Quarter 2026 Results

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

McGraw Hill, Inc. Reports Strong Fiscal First Quarter 2027 Results Exceeding Expectations

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001918704-26-023648 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - Silo Pharma, Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088836 <b>Size:</b> 12 KB

New Form 424B2 - NOMURA HOLDINGS INC <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001104659-26-095587 <b>Size:</b> 1 MB

New Form SCHEDULE 13G/A - Sunshine Biopharma Inc. <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0001213900-26-088834 <b>Size:</b> 11 KB